HeartForce has embarked on Phase 1 of a Verification Study in Uzbekistan. This significant undertaking follows the successful development of the EMR Score in a prior study.
In this new phase, HeartForce is in the process of acquiring a comprehensive verification database, meticulously designed to closely resemble the characteristics of the actual target population. This new database will encompass data from 600 new patients, and its primary objective is to rigorously assess the accuracy and efficacy of the EMR Score. The results of this verification study will be pivotal for HeartForce’s regulatory submissions to Health Canada and the FDA.